• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Restoration of W1282X CFTR activity by enhanced expression.通过增强表达恢复W1282X囊性纤维化跨膜传导调节因子的活性。
Am J Respir Cell Mol Biol. 2007 Sep;37(3):347-56. doi: 10.1165/rcmb.2006-0176OC. Epub 2007 May 31.
2
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor.合成氨基糖苷类药物能有效抑制囊性纤维化跨膜电导调节因子无义突变,并被依伐卡托增强。
Am J Respir Cell Mol Biol. 2014 Apr;50(4):805-16. doi: 10.1165/rcmb.2013-0282OC.
3
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.静脉注射庆大霉素对囊性纤维化患者终止密码子抑制的体外预测:一项初步研究。
BMC Med. 2007 Mar 29;5:5. doi: 10.1186/1741-7015-5-5.
4
Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations.新型校正剂和增强剂可提高囊性纤维化跨膜传导调节因子无义突变的翻译通读效率。
Am J Respir Cell Mol Biol. 2021 May;64(5):604-616. doi: 10.1165/rcmb.2019-0291OC.
5
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.庆大霉素诱导纠正囊性纤维化和CFTR截短突变患者的CFTR功能。
N Engl J Med. 2003 Oct 9;349(15):1433-41. doi: 10.1056/NEJMoa022170.
6
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation.在一名W1282X囊性纤维化跨膜传导调节因子(CFTR)无义突变纯合的囊性纤维化(CF)患者中观察到CFTR增强剂依伐卡托的治疗益处。
J Cyst Fibros. 2017 Jan;16(1):24-29. doi: 10.1016/j.jcf.2016.09.005. Epub 2016 Oct 1.
7
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.无义介导的mRNA降解影响无义转录本水平,并决定囊性纤维化患者对庆大霉素的反应。
J Clin Invest. 2007 Mar;117(3):683-92. doi: 10.1172/JCI28523. Epub 2007 Feb 8.
8
Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids.CFTR 无义突变导致的囊性纤维化在肠道类器官中,通读试剂对提前终止密码子的抑制作用有限。
J Cyst Fibros. 2016 Mar;15(2):158-62. doi: 10.1016/j.jcf.2015.07.007. Epub 2015 Aug 5.
9
Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action.通过抑制无意义介导的衰变和具有互补作用机制的蛋白质调节剂,在患者来源的鼻培养物中实现了 c.3846G>A(W1282X) 的功能挽救。
J Cyst Fibros. 2020 Sep;19(5):717-727. doi: 10.1016/j.jcf.2019.12.001. Epub 2019 Dec 9.
10
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54.合成氨基糖苷 NB54 抑制 CFTR 过早终止密码子并拯救 CFTR 蛋白和功能。
J Mol Med (Berl). 2011 Nov;89(11):1149-61. doi: 10.1007/s00109-011-0787-6. Epub 2011 Jul 22.

引用本文的文献

1
Repair of CRISPR-guided RNA breaks enables site-specific RNA excision in human cells.CRIPSR 引导的 RNA 断裂修复可实现人类细胞中特定位点的 RNA 切除。
Science. 2024 May 17;384(6697):808-814. doi: 10.1126/science.adk5518. Epub 2024 Apr 25.
2
Q1291H-CFTR molecular dynamics simulations and theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient.Q1291H-CFTR分子动力学模拟以及在鼻上皮模型中的分型与一名Q1291H/F508del患者对依列卡福/替扎卡福/依伐卡福的临床反应
Front Mol Biosci. 2023 Jun 1;10:1148501. doi: 10.3389/fmolb.2023.1148501. eCollection 2023.
3
The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators.合成的氨基糖苷类药物 ELX-02 诱导 G550X-CFTR 产生超功能蛋白,CFTR 调节剂可进一步增强该蛋白的功能。
Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L756-L770. doi: 10.1152/ajplung.00038.2023. Epub 2023 Apr 4.
4
Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis.基于基因、RNA 和 ASO 的囊性纤维化治疗方法。
J Cyst Fibros. 2023 Mar;22 Suppl 1(Suppl 1):S39-S44. doi: 10.1016/j.jcf.2022.12.016. Epub 2023 Jan 17.
5
Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy.针对囊性纤维化治疗的基因特异性无意义介导的 mRNA 衰减。
Nat Commun. 2022 May 27;13(1):2978. doi: 10.1038/s41467-022-30668-y.
6
CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway.具有无义密码子的 CFTR mRNAs 可被 SMG6 介导的核酸内切酶降解途径降解。
Nat Commun. 2022 Apr 29;13(1):2344. doi: 10.1038/s41467-022-29935-9.
7
Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway.气道中前列腺素信号通路介导的 CFTR 受体激活。
Am J Physiol Lung Cell Mol Physiol. 2022 Mar 1;322(3):L305-L314. doi: 10.1152/ajplung.00388.2021. Epub 2022 Jan 12.
8
Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis.使用剪接转换反义寡核苷酸进行开放阅读框校正治疗囊性纤维化。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2114886119.
9
Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.用于囊性纤维化治疗的外显子跳跃反义寡核苷酸。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2114858118.
10
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.依伐卡托/泰它卡托/艾氟卡托治疗囊性纤维化的临床疗效:一项临床试验。
Am J Respir Crit Care Med. 2022 Mar 1;205(5):529-539. doi: 10.1164/rccm.202108-1986OC.

本文引用的文献

1
No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations.在患有囊性纤维化且存在终止突变的患者中,鼻用氨基糖苷类药物未使囊性纤维化跨膜传导调节因子出现可检测到的改善。
Am J Respir Cell Mol Biol. 2007 Jul;37(1):57-66. doi: 10.1165/rcmb.2006-0173OC. Epub 2007 Mar 8.
2
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.无义介导的mRNA降解影响无义转录本水平,并决定囊性纤维化患者对庆大霉素的反应。
J Clin Invest. 2007 Mar;117(3):683-92. doi: 10.1172/JCI28523. Epub 2007 Feb 8.
3
Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains.姜黄素通过一种既不需要ATP结合也不需要核苷酸结合结构域二聚化的新机制打开囊性纤维化跨膜传导调节通道。
J Biol Chem. 2007 Feb 16;282(7):4533-4544. doi: 10.1074/jbc.M609942200. Epub 2006 Dec 18.
4
Domain interdependence in the biosynthetic assembly of CFTR.囊性纤维化跨膜传导调节因子生物合成组装中的结构域相互依赖性。
J Mol Biol. 2007 Jan 26;365(4):981-94. doi: 10.1016/j.jmb.2006.10.086. Epub 2006 Nov 10.
5
Nonsense mutations: running the red light.无义突变:闯红灯
Nature. 2005 Dec 8;438(7069):726-8. doi: 10.1038/438726a.
6
Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers.环磷酸腺苷(cAMP)激动剂无法激活CFBE41o-气道上皮单层中挽救的ΔF508囊性纤维化跨膜传导调节因子(CFTR)。
J Physiol. 2005 Dec 1;569(Pt 2):601-15. doi: 10.1113/jphysiol.2005.096669. Epub 2005 Oct 6.
7
Cystic fibrosis.囊性纤维化
N Engl J Med. 2005 May 12;352(19):1992-2001. doi: 10.1056/NEJMra043184.
8
Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.囊性纤维化跨膜传导调节因子(CFTR)的正常门控需要ATP与两个核苷酸结合结构域结合,并在第二个核苷酸结合结构域进行水解。
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):455-60. doi: 10.1073/pnas.0408575102. Epub 2004 Dec 27.
9
The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.ΔF508 囊性纤维化突变会损害结构域间的相互作用,并阻止囊性纤维化跨膜传导调节因子(CFTR)的翻译后折叠。
Nat Struct Mol Biol. 2005 Jan;12(1):17-25. doi: 10.1038/nsmb882. Epub 2004 Dec 26.
10
Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.CFTR氨基末端核苷酸结合结构域中非保守结构片段的功能作用。
J Gen Physiol. 2005 Jan;125(1):43-55. doi: 10.1085/jgp.200409174. Epub 2004 Dec 13.

通过增强表达恢复W1282X囊性纤维化跨膜传导调节因子的活性。

Restoration of W1282X CFTR activity by enhanced expression.

作者信息

Rowe Steven M, Varga Karoly, Rab Andras, Bebok Zsuzsa, Byram Kevin, Li Yao, Sorscher Eric J, Clancy John P

机构信息

Department of Medicine, Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006, USA.

出版信息

Am J Respir Cell Mol Biol. 2007 Sep;37(3):347-56. doi: 10.1165/rcmb.2006-0176OC. Epub 2007 May 31.

DOI:10.1165/rcmb.2006-0176OC
PMID:17541014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1994229/
Abstract

Cystic fibrosis results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Premature termination codons represent a common minority of CFTR mutations, and are caused by base pair substitutions that produce abnormal stop codons in the coding sequence. Select aminoglycosides induce "translational readthrough" of premature stop codons and have been shown to restore full-length functional protein in a number of preclinical and clinical settings. We studied two well-described premature termination codons found in the distal open reading frame of CFTR, W1282X and R1162X, expressed in polarizing and nonpolarizing cells. Our findings indicate that W1282X CFTR-expressing cells demonstrate significantly greater CFTR activity when overexpressed compared with R1162X CFTR cells, even when truncated protein is the predominant form. In addition, our results show that the combination of stimulated expression and stop codon suppression produces additive effects on CFTR-mediated ion transport. These findings provide evidence that W1282X CFTR exhibits membrane localization and retained chloride channel function after enhanced expression, and suggest that patients harboring this mutation may be more susceptible to CFTR rescue.

摘要

囊性纤维化由囊性纤维化跨膜传导调节因子(CFTR)基因突变引起。过早终止密码子是CFTR突变中常见的少数类型,由编码序列中产生异常终止密码子的碱基对替换所致。某些氨基糖苷类药物可诱导过早终止密码子的“翻译通读”,并已证实在一些临床前和临床环境中能恢复全长功能性蛋白。我们研究了在CFTR远端开放阅读框中发现的两个已充分描述的过早终止密码子W1282X和R1162X,它们在极化和非极化细胞中表达。我们的研究结果表明,与R1162X CFTR细胞相比,过表达时表达W1282X CFTR的细胞表现出显著更高的CFTR活性,即使截短蛋白是主要形式。此外,我们的结果表明,刺激表达和终止密码子抑制的组合对CFTR介导的离子转运产生累加效应。这些发现证明W1282X CFTR在增强表达后表现出膜定位并保留了氯离子通道功能,提示携带此突变的患者可能更容易从CFTR挽救治疗中获益。